High-Resolution Single Particle Zeta Potential Characterisation of Biological Nanoparticles Using Tunable Resistive Pulse Sensing
Authors
Affiliations
Physicochemical properties of nanoparticles, such as size, shape, surface charge, density, and porosity play a central role in biological interactions and hence accurate determination of these characteristics is of utmost importance. Here we propose tunable resistive pulse sensing for simultaneous size and surface charge measurements on a particle-by-particle basis, enabling the analysis of a wide spectrum of nanoparticles and their mixtures. Existing methodologies for measuring zeta potential of nanoparticles using resistive pulse sensing are significantly improved by including convection into the theoretical model. The efficacy of this methodology is demonstrated for a range of biological case studies, including measurements of mixed anionic, cationic liposomes, extracellular vesicles in plasma, and in situ time study of DNA immobilisation on the surface of magnetic nanoparticles. The high-resolution single particle size and zeta potential characterisation will provide a better understanding of nano-bio interactions, positively impacting nanomedicine development and their regulatory approval.
The Role of Exosomes in Cancer Progression and Therapy.
Sergazy S, Seydahmetova R, Gulyayev A, Shulgau Z, Aljofan M Biology (Basel). 2025; 14(1).
PMID: 39857258 PMC: 11763171. DOI: 10.3390/biology14010027.
Targeting CHEK1: Ginsenosides-Rh2 and Cu2O@G-Rh2 nanoparticles in thyroid cancer.
Wang L, Wu X, Wang X, Dong M, Zhang H, Zhao P Cell Biol Toxicol. 2025; 41(1):30.
PMID: 39808342 PMC: 11732901. DOI: 10.1007/s10565-024-09961-7.
Development of amphiphilic self-assembled nucleolipid as BBB targeting probe based on SPECT.
Tiwari S, Chaturvedi S, Kaul A, Choudhary V, Barthelemy P, Mishra A Discov Nano. 2024; 19(1):210.
PMID: 39690348 PMC: 11652433. DOI: 10.1186/s11671-024-04129-y.
Current state of nanomedicine drug products: An industry perspective.
Clogston J, Foss W, Harris D, Oberoi H, Pan J, Pu E J Pharm Sci. 2024; 113(12):3395-3405.
PMID: 39276979 PMC: 11649492. DOI: 10.1016/j.xphs.2024.09.005.
Characterization of lipid-based nanomedicines at the single-particle level.
Chen C, Chen C, Li Y, Gu R, Yan X Fundam Res. 2024; 3(4):488-504.
PMID: 38933557 PMC: 11197724. DOI: 10.1016/j.fmre.2022.09.011.